Lexpos News

Pharmacy owners and their teams can now watch an on-demand recording of Community Pharmacy England’s webinar giving an overview of the Pharmacy First service. Held earlier this week, over 500 people tuned in to watch our ‘Pharmacy First: Getting to know the service’ webinar. The first in our series of webinars* aimed at assisting the [...]

The post Watch our Pharmacy First: Getting to know the service webinar appeared first on Community Pharmacy England.

The Chief Pharmaceutical Officer (CPhO) for England, David Webb, has written to the community pharmacy sector about the Pharmacy First service in an end of year letter. Whilst thanking pharmacy colleagues for making a “valuable contribution” to the NHS this year, the CPhO notes that the agreement of the national Pharmacy First service marks a [...]

The post Chief Pharmaceutical Officer writes to sector about Pharmacy First appeared first on Community Pharmacy England.

Pharmacy owners have until Sunday (17th December 2023) to complete the 2023 workforce survey, which is a mandatory requirement for all pharmacy owners. The NHS Business Services Authority sent an email to pharmacy owners containing a link to the survey on 23rd October 2023; the survey can also be accessed via the following link: Access [...]

The post 2023 mandatory workforce survey closes on Sunday appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has via its Central Alerting System (CAS) published a letter on 14 December 2023 advising that due to increasing flu levels in the community, Prescribers working in primary care may now prescribe, and community pharmacists may now supply antiviral medicines (oseltamivir and zanamivir) for the prophylaxis and treatment [...]

The post DHSC permits use of antiviral medicines against influenza appeared first on Community Pharmacy England.

Drug alert number: EL (23)A/44 Date issued: 14 December 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Posaconazole Biocon 100mg Gastro-resistant Tablets (Biocon Pharma UK Limited) PL 50674/0011 SNOMED Code: N/A Batch Number Expiry Date Pack Size First Distributed BF22004504 Dec-2024 12 x 8 27th April [...]

The post MHRA Class 3 Medicines Recall: Posaconazole Biocon 100mg Gastro-resistant Tablets (Biocon Pharma UK Limited) appeared first on Community Pharmacy England.